These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 33331874)

  • 1. Using Historical Data to Support Approval of Drug Products for Ophthalmia Neonatorum: Innovative Approach Toward Evidence-Based Medicine.
    Sun H; Temeck JW; McCune SK; Chambers WA
    JAMA Ophthalmol; 2021 Feb; 139(2):214-217. PubMed ID: 33331874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of conjunctivitis].
    Barabási Z
    Orv Hetil; 2004 Oct; 145(41):2107-10. PubMed ID: 15586586
    [No Abstract]   [Full Text] [Related]  

  • 3. Neonatal ocular prophylaxis in the United States: is it still necessary?
    Franco S; Hammerschlag MR
    Expert Rev Anti Infect Ther; 2023 May; 21(5):503-511. PubMed ID: 36691840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular medications in children.
    Wallace DK; Steinkuller PG
    Clin Pediatr (Phila); 1998 Nov; 37(11):645-52. PubMed ID: 9825207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacterial conjunctivitis].
    Hørven I
    Tidsskr Nor Laegeforen; 1994 Feb; 114(6):661. PubMed ID: 8191443
    [No Abstract]   [Full Text] [Related]  

  • 6. Klebsiella pneumonia: An unusual cause of ophthalmia neonatorum in a healthy newborn.
    Kumar JB; Silverstein E; Wallace DK
    J AAPOS; 2015 Dec; 19(6):564-6. PubMed ID: 26691043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial.
    Baiza-Durán L; Olvera-Montaño O; Mercado-Sesma AR; Oregon-Miranda AA; Lizárraga-Corona A; Ochoa-Tabares JC; Pérez-Balbuena AL; Montoya-Sánchez IM; Saucedo-Rodríguez LR; Mora-González A; Gómez-Bastar PA; Villanueva-Najera MA; Sandoval-Delgadillo LI; González-Lomelí M; Páez-Garza JH; Orozco-Carroll M; Casillas-Magallanes M
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):250-255. PubMed ID: 29624493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of ophthalmia neonatorum: comparison of silver nitrate, tetracycline, erythromycin and no prophylaxis.
    Chen JY
    Pediatr Infect Dis J; 1992 Dec; 11(12):1026-30. PubMed ID: 1461692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
    McDonald MB; Protzko EE; Brunner LS; Morris TW; Haas W; Paterno MR; Comstock TL; Usner DW
    Ophthalmology; 2009 Sep; 116(9):1615-1623.e1. PubMed ID: 19643483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of topical ophthalmic prophylaxis in prevention of ophthalmia neonatorum.
    Matinzadeh ZK; Beiragdar F; Kavemanesh Z; Abolgasemi H; Amirsalari S
    Trop Doct; 2007 Jan; 37(1):47-9. PubMed ID: 17326893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.
    Comstock TL; Paterno MR; Usner DW; Pichichero ME
    Paediatr Drugs; 2010 Apr; 12(2):105-12. PubMed ID: 20218747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we use azithromycin eye drops for gonococcal ophthalmia prophylaxis in the United States?
    Franco S; Hammerschlag MR
    Expert Rev Anti Infect Ther; 2024 Jun; 22(6):373-377. PubMed ID: 38781483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.
    Benitez-Del-Castillo J; Verboven Y; Stroman D; Kodjikian L
    Clin Drug Investig; 2011; 31(8):543-557. PubMed ID: 21604820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Besifloxacin: a topical fluoroquinolone for the treatment of bacterial conjunctivitis.
    Chang MH; Fung HB
    Clin Ther; 2010 Mar; 32(3):454-71. PubMed ID: 20399984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of silver nitrate with erythromycin for prophylaxis against ophthalmia neonatorum.
    Zanoni D; Isenberg SJ; Apt L
    Clin Pediatr (Phila); 1992 May; 31(5):295-8. PubMed ID: 1582096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis: data from six clinical and phase I safety studies.
    Comstock TL; Paterno MR; Decory HH; Usner DW
    Clin Drug Investig; 2010; 30(10):675-85. PubMed ID: 20629472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
    Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL
    Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morganella as a cause of ophthalmia neonatorum.
    Ward MF; Olson DJ; Taggart M; Grace SF
    J AAPOS; 2018 Feb; 22(1):81-82. PubMed ID: 29288840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmia neonatorum with special reference to Chlamydia trachomatis. Diagnosis and treatment.
    Sandström I
    Acta Paediatr Scand Suppl; 1986; 330():1-27. PubMed ID: 3107338
    [No Abstract]   [Full Text] [Related]  

  • 20. Conjunctivitis of the newborn.
    de Toledo AR; Chandler JW
    Infect Dis Clin North Am; 1992 Dec; 6(4):807-13. PubMed ID: 1460264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.